A critical discovery in cancer study is occurring with the use of nanobodies to reactivate dysfunctional p53. This vital cancer protector protein is frequently disabled in several types of tumors, leading uncontrolled https://listingbookmarks.com/story21978106/nanobodies-reactivate-tumor-suppressor-p53-a-potential-hope-for-cancer-treatment